ASO Author Reflections: Hepatocellular Carcinoma-Related Tumor Necrosis is Associated with Worse Long-Term Outcomes.
作者信息
Zhang Xu-Feng, Pawlik Timothy M
机构信息
Department of Hepatobiliary and Pancreatic Surgery and Institute of Advanced Surgical Technology and Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Surgery, The Urban Meyer III and Shelley Meyer Chair for Cancer Research, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
出版信息
Ann Surg Oncol. 2021 Feb;28(2):806-807. doi: 10.1245/s10434-020-09396-4. Epub 2020 Nov 25.
PMID:33237450
Abstract
摘要
相似文献
1
ASO Author Reflections: Hepatocellular Carcinoma-Related Tumor Necrosis is Associated with Worse Long-Term Outcomes.
Ann Surg Oncol. 2021 Feb;28(2):806-807. doi: 10.1245/s10434-020-09396-4. Epub 2020 Nov 25.
2
ASO Author Reflections: A New Look at the Clinical Significance of MVI in Hepatocellular Carcinoma.ASO作者反思：肝细胞癌微血管侵犯临床意义的新视角
Ann Surg Oncol. 2019 Dec;26(Suppl 3):617-618. doi: 10.1245/s10434-019-07364-1. Epub 2019 May 20.
3
ASO Author Reflections: Identifying Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.ASO作者反思：确定伴有门静脉癌栓的肝细胞癌的最佳手术候选者
Ann Surg Oncol. 2019 Dec;26(Suppl 3):551-552. doi: 10.1245/s10434-018-7018-0. Epub 2018 Dec 18.
4
ASO Author Reflections: Impact of Borderline Nodules Incidentally Detected by MRI for Prognosis of Hepatocellular Carcinoma After Hepatectomy.ASO作者反思：MRI偶然发现的边缘性结节对肝癌肝切除术后预后的影响
Ann Surg Oncol. 2020 Sep;27(9):3354-3355. doi: 10.1245/s10434-020-08421-w. Epub 2020 Apr 3.
5
ASO Author Reflections: Preoperative Hypercoagulability Predicts Poor Prognosis in Hepatocellular Carcinoma Patients with Microvascular Invasion After Hepatectomy.ASO作者反思：术前高凝状态预示肝切除术后微血管侵犯的肝细胞癌患者预后不良。
Ann Surg Oncol. 2019 Dec;26(Suppl 3):806-807. doi: 10.1245/s10434-019-07986-5. Epub 2019 Oct 25.
6
ASO Author Reflections: Does Anatomic Resection Improve Prognosis for Hepatocellular Carcinoma? Assessment from Recurrence Treatment.ASO作者反思：解剖性切除是否能改善肝细胞癌的预后？来自复发治疗的评估。
Ann Surg Oncol. 2022 Feb;29(2):922-923. doi: 10.1245/s10434-021-10439-7. Epub 2021 Sep 13.
7
ASO Author Reflections: Pre-transplant Treatments for Patients with Hepatocellular Carcinoma Before Liver Transplantation.ASO作者反思：肝细胞癌患者肝移植前的移植前治疗
Ann Surg Oncol. 2023 Mar;30(3):1420-1421. doi: 10.1245/s10434-022-12964-5. Epub 2023 Jan 13.
8
ASO Author Reflections: Understanding How to Improve Surveillance in Hepatocellular Carcinoma.ASO作者反思：理解如何改善肝细胞癌的监测
Ann Surg Oncol. 2022 Dec;29(13):8432-8433. doi: 10.1245/s10434-022-12523-y. Epub 2022 Sep 13.
9
ASO Author Reflections: Resection for Hepatocellular Carcinoma Beyond the BCLC Guidelines-How Can Machine Learning Techniques Help?ASO作者反思：超出BCLC指南的肝细胞癌切除术——机器学习技术如何提供帮助？
Ann Surg Oncol. 2020 Mar;27(3):875-876. doi: 10.1245/s10434-019-08036-w. Epub 2019 Nov 4.
10
ASO Author Reflections: The Role of Postoperative Adjuvant Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma and Hepatic Vein Invasion.ASO作者反思：经动脉化疗栓塞术在肝细胞癌合并肝静脉侵犯患者术后辅助治疗中的作用
Ann Surg Oncol. 2019 Dec;26(Suppl 3):709-710. doi: 10.1245/s10434-019-07672-6. Epub 2019 Aug 29.
本文引用的文献
1
Targeting Myeloid-Derived Suppressor Cells for Premetastatic Niche Disruption After Tumor Resection.肿瘤切除后针对骨髓源性抑制细胞的前转移龛破坏。
Ann Surg Oncol. 2021 Jul;28(7):4030-4048. doi: 10.1245/s10434-020-09371-z. Epub 2020 Nov 30.
Zotero 插件